BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bragança B, Correia-de-Sá P. Resolving the Ionotropic P2X4 Receptor Mystery Points Towards a New Therapeutic Target for Cardiovascular Diseases. Int J Mol Sci 2020;21:E5005. [PMID: 32679900 DOI: 10.3390/ijms21145005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Toti KS, Verma R, McGonnigle MJ, Gamiotea Turro D, Wen Z, Lewicki SA, Liang BT, Jacobson KA. Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2H-naphtho[1,2-b][1,4]diazepine-2,4(3H)-diones as P2X4 Receptor Antagonists. J Med Chem 2022. [PMID: 36150180 DOI: 10.1021/acs.jmedchem.2c01197] [Reference Citation Analysis]
2 Cuthbertson P, Elhage A, Al-Rifai D, Sophocleous RA, Turner RJ, Aboelela A, Majed H, Bujaroski RS, Jalilian I, Kelso MJ, Watson D, Buckley BJ, Sluyter R. 6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist. Biomolecules 2022;12:1309. [PMID: 36139148 DOI: 10.3390/biom12091309] [Reference Citation Analysis]
3 Sophocleous RA, Ooi L, Sluyter R. The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target. Int J Mol Sci 2022;23:5739. [PMID: 35628550 DOI: 10.3390/ijms23105739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bhattacharyya A, Torre P, Yadav P, Boostanpour K, Chen TY, Tsukui T, Sheppard D, Muramatsu R, Seed RI, Nishimura SL, Jung JB, Tang X, Allen CDC, Bhattacharya M. Macrophage Cx43 Is Necessary for Fibroblast Cytosolic Calcium and Lung Fibrosis After Injury. Front Immunol 2022;13:880887. [DOI: 10.3389/fimmu.2022.880887] [Reference Citation Analysis]
5 Bajrami B, Martin JG, Johnson DS. Utility of chemical probes for mass spectrometry based chemical proteomics. Advances in Chemical Proteomics 2022. [DOI: 10.1016/b978-0-12-821433-6.00003-9] [Reference Citation Analysis]
6 Woodbury DJ, Whitt EC, Coffman RE. A review of TNP-ATP in protein binding studies: benefits and pitfalls. Biophysical Reports 2021;1:100012. [DOI: 10.1016/j.bpr.2021.100012] [Reference Citation Analysis]
7 Pérez-Sen R, Delicado EG. Dissecting the Purinergic Signaling Puzzle. Int J Mol Sci 2021;22:8925. [PMID: 34445630 DOI: 10.3390/ijms22168925] [Reference Citation Analysis]
8 Kanellopoulos JM, Almeida-da-Silva CLC, Rüütel Boudinot S, Ojcius DM. Structural and Functional Features of the P2X4 Receptor: An Immunological Perspective. Front Immunol 2021;12:645834. [PMID: 33897694 DOI: 10.3389/fimmu.2021.645834] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
9 Ai X, Dong X, Guo Y, Yang P, Hou Y, Bai J, Zhang S, Wang X. Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment. Purinergic Signal 2021;17:229-40. [PMID: 33751327 DOI: 10.1007/s11302-021-09774-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Illes P, Müller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F. Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 2021;178:489-514. [PMID: 33125712 DOI: 10.1111/bph.15299] [Cited by in Crossref: 78] [Cited by in F6Publishing: 85] [Article Influence: 39.0] [Reference Citation Analysis]